Presence of HLA-C-restricted cytotoxic T-lymphocyte responses in long-term nonprogressors infected with human immunodeficiency virus

Viral Immunology

Volumn 11, Issue 3, 1998, Pages 119-129

  Nehete, Pramod N ^a   Lewis, Dorothy E ^b   Tang, Derek N G ^b   Pollack, Marilyn S ^b   Sastry, K Jagannadha ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; HLA C ANTIGEN;

ARTICLE; B LYMPHOCYTE; CASE REPORT; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOID CELL LINE; TARGET CELL; VIRUS IMMUNITY;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MURINAE; PRIMATES; RNA VIRUSES;

EID: 0032416535     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/vim.1998.11.119     Document Type: Article

References (44)

1. Bogedain, C., H. Wolf, S. Modrow, G. Stuber, and W. Jilg. 1995. Specific cytotoxic T lymphocytes recognize the immediate-early transactivator Zta of Epstein-Barr virus. J. Virol. 69:4872-4879.
2. Carmichael, A., X. Jin, P. Sissons, and L. Borysiewicz. 1993. Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: Differential CTL responses to HIV-1 and Epstein-Barr virus in late disease. J. Exp. Med. 177:249-256.
3. Clerici, M., J.A. Berzofsky, G.M. Shearer, and C.O. Tacket. 1991. Exposure to human immunodeficiency virus type 1-specific T helper cell responses before detection of infection by polymerase chain reaction and serum antibodies. J. Infect. Dis. 164:178-182.
4. Collins, K.L., B.K. Chen, S.A. Kalams, B.D. Walker and D. Baltimore. 1998. HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes. Nature 391:397-401.
5. Dadaglio, G., A. Leroux, P. Langlade-Demoyen, E.M. Bahraoui, F. Traincard, R. Fisher, and F. Plata. 1991. Epitope recognition of conserved HIV envelope sequences by human cytotoxic T lymphocytes. J. Immunol. 147:2302-2309.
6. Dai, L.C., K. West, R. Littaua, K. Takahashi, and F.A. Ennis. 1992. Mutation of human immunodeficiency virus type 1 at amino acid 585 on gp41 results in loss of killing by CDS+ A24-restricted cytotoxic T lymphocytes. J. Virol. 66:3151-3154.
7. Dill, O.F., F. Kievits, S. Koch, P. Ivanyi, and G.J. Hammerling. 1988. Immunological function of HLA-C antigens in HLA-Cw3 transgenic mice. Proc. Natl. Acad. Sci. USA 85:5664-5668.
8. Dupuis, M., S.K. Kundu, and T.C. Merigan. 1995. Characterization of HLA-A *0201-restricted cytotoxic T cell epitopes in conserved regions of the HIV type 1 gp160 protein. J. Immunol. 155:2232-2239.
9. Falk, K., O. Ritzschke, B. Grahovac, D. Schendel, S. Stevanovic, V. Gnau, G. Jung, J.L. Strominger, and H.G. Rammensee. 1993. Allele specific peptide ligand motifs of HLA-C molecules. Proc. Natl. Acad. Sci. USA 90:12005-12009.
10. Falk, C.S., A. Steinle, and D.J. Schendel. 1995. Expression of HLA-C molecules confers target cell resistance to some non-major histocompatibility complex-restricted T cells in a manner analogous to allospecific natural killer cells. J. Exp. Med. 182:1005-1018.
11. Gasson, D., R.S. Rein, I. Mejer, W. Hoog, G.H.A. Seemann, F.M. Hochstenback, and H.L. Ploegh. 1987. Isolation, expression, and the primary structure of HLA-Cw1 and HLA-Cw2 genes: Evolutionary aspects. Immunogenetics 25:313-322.
12. Haynes, B.F., G. Pantaleo, and A.S. Fauci. 1996. Toward an understanding of the correlates of protective immunity to HIV infection. Science 274:324-328.
13. Houghten, R.A. 1985. General method for the rapid solid-phase synthesis of large numbers of peptides: Specificity of antigen-antibody interaction at the level of individual amino acids. Proc. Natl. Acad. Sci. USA 82:5131-5135.
14. Howcroft, T.K., K. Strebel, M.A. Martin, and D.S. Singer. 1993. Repression of MHC class I gene promoter activity by two-exon tat of HIV. Science 260:1320-1322.
15. Jassoy, C., R.P. Johnson, B.A. Navia, J. Worth, and B.D. Walker. 1992. Detection of a vigorous HIV-1-specific cytotoxic T lymphocyte response in cerebrospinal fluid from infected persons with AIDS dementia complex. J. Immunol. 149:3113-3119.
16. Johnson, R.P., A. Trocha, T.M. Buchanan, and B.D. Walker. 1993. Recognition of a highly conserved region of human immunodeficiency virus type 1 gp120 by an HLA-Cw4-restricted cytotoxic T-lymphocyte clone. J. Virol. 67:438-445.
17. Johnson, R.P., A. Trocha, T.M. Buchanan, and B.D. Walker. 1992. Identification of overlapping HLA class I-restricted cytotoxic T cell epitopes in a conserved region of the human immunodeficiency virus type 1 envelope glycoprotein: Definition of minimum epitopes and analysis of the effects of sequence variation. J. Exp. Med. 175:961-971.
18. Just, J.J. 1995. Genetic predisposition to HIV-1 infection and acquired immune deficiency virus syndrome: A review of the literature examining association with HLA. Hum. Immunol. 44:156-169.
19. Kerkau, T., I. Bacik, J.R. Bennink, J.W. Yewdell, T. Hunig, A. Schimpl, and U. Schubert. 1997. The human immunodeficiency virus type 1 (HIV-1) Vpu protein interferes with an early step in the biosynthesis of major histocompatibility complex (MHC) class I molecules. J. Exp. Med. 185:1295-1305.
20. Klein, M.R., C.A. van Baalen, A.M. Holwerda, S.R. Kerkhof-Garde, RJ. Bende, I.P.M. Keet, J.M. Eeftinck-Schattenkerk, A. Osterhaus, H. Schuitemaker, and F. Miedema. 1995. Kinetics of gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: A longitudinal analysis of rapid progressors and long-term asymptomatics. J. Exp. Med. 181:1365-1372.
21. Koup, R.A., J.T. Safrit, Y. Cao, C.A. Andrews, G. McLeod, W. Borkowsky, C. Farthing, and D.D. Ho. 1994. Temporal associations of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J. Virol. 68:4650-4655.
22. Lifson, A.R., S.P. Buchbinder, H.W. Sheppard, A.C. Mawle, J.C. Wilber, M. Stanley, C.E. Hart, N.A. Hessor, and S.D. Holmberg. 1991. Long-term human immunodeficiency virus infection in asymptomatic homosexual and bisexual men with normal CD4+ lymphocyte counts: Immunologic and virologic characteristics. J. Infect. Dis. 163:959-965.
23. Littaua, R.A., M.B.A. Oldstone, A. Takeda, C. Debouck, W.T. Wong, C.U. Tuazon, B. Moss, F. Kievits, and F.A. Ennis. 1991. An HLA-C-restricted CD8+ cytotoxic T-lymphocyte clone recognizes a highly conserved epitope on human immunodeficiency virus type 1 gag. J. Virol. 65:4051-4056.
24. McMichael, A.J., A. Ting, H.J. Zweerink, and B.A. Askonas. 1977. HLA restriction of cell-mediated lysis of influenza virus-infected human cells. Nature 270:524-546.
25. Merrifield, R.B. 1963. Solid phase peptide synthesis. J. Am. Chem. Soc. 85:2149-2154.
26. Munoz, A.A., A.J. Kirby, Y.D. He, J.B. Margolick, B.R. Visscher, C.R. Rinaldo, R.A. Kaslow, and J.P. Phai. 1995. Long-term survivors with HIV-1 infection: incubation period and longitudinal patterns of CD4+1 lymphocytes. J. Acquir. Immune Syndr. Hum. Retrovir. 8:496-505.
27. Musey, L., J. Hughes, T. Schacker, T. Shea, L. Corey, and M.J. McElrath. 1997. Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection. N. Engl. J. Med. 337:1267-1274.
28. Nehete, P.N., W.C. Satterfield, C.M. Matherne, R.B. Arlinghaus, and K.J. Sastry. 1993. Induction of human immunodeficiency virus-specific T cell responses in Rhesus monkeys by synthetic peptides from gp160. AIDS Res. Hum. Retrovir 9:235-240.
29. Nixon, D.F., and A.J. McMichael. 1991. Cytotoxic T cell recognition of HIV proteins and peptides. AIDS 5:1049-1059.
30. Olerum, O., and H. Zetterquist. 1992. HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: An alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tiss. Antigens 39:225-235.
31. Pantaleo, G., J.F. Demarest, H. Soudeyns, C. Graziosi, F. Denis, J.W. Adelsberger, P.M. Borrow, M.S. Saag, G.M. Shaw, R.P. Sekaly, and A.S. Fauci. 1994. Major expansion of CD8+ T cells with a predominant Vβ usage during the primary immune responses to HIV. Nature 370:463-467.
32. Picard, O., A. Achour, J. Bernard, A. Halbreich, B. Bizzini, V. Boyer, C. Desgranges, J.M. Bertho, A. Lachgar, B. Polliotti, M.C. Defere, K. Lanneval, J.C. Imbert, J. Frottier, J.J. Salaun, A. Burny, and D. Zagury. 1992. A 2-year follow-up of an anti-HIV immune reaction in HIV-1 gp160-immunized healthy seronegative humans: Evidence for persistent cell-mediated immunity. J. Acquir. Immune Defic. Syndr. 5:539-546.
33. Rinaldo, C., X.L. Huang, Z. Fan, M. Ding, L. Beltz, A. Logar, D. Panicali, G. Mazzara, J. Liebmann, M. Cottrill, and P. Gupta. 1995. High levels of anti-human immunodeficiency virus type 1 (HIV-1) memory cytotoxic T lymphocyte activity and low viral load are associated with lack of disease in HIV-1 infected long-term nonprogressors. J. Virol. 69:5838-5842.
34. Roos, M.L.T., F. Miedema, M. Koot, M. Tersmette, W.P. Schaasberg, R.A. Coutinho, and P.T.A. Schellekens. 1995. T cell function in vitro is an independent progression marker for AIDS in human immunodeficiency virus-infected asymptomatic subjects. J. Infect. Dis. 171:531-536.
35. Rosenberg, E.S., J.M. Billingsley, A.M. Caliendo, S.L. Boswell, P.E. Sax, S.A. Kalams, and B.D. Walker. 1997. Vigorous HIV-1-specific CD4+T T cell responses associated with control of viremia. Science 278:1447-1450.
36. Rowland-Jones, S.L., D.F. Nixon, M.C. Aldhous, F. Gotch, K. Ariyoshi, N. Hallam, J.S. Kroll, K. Froebel, and A. McMichael. 1993. HIV-specific CTL activity in an HIV-exposed but uninfected infant. Lancet 341:860-861.
37. Rowland-Jones, S.L., J. Sutton, K. Ariyoshi, T. Dong, F. Gotch, S. McAdam, D. Whitby, S. Sabally, A. Gallimore, T. Corrah, M. Takiguchi, T. Schultz, A. McMichael, and H. Whittle. 1995. HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women. Nature Med. 1:59-64.
38. Sastry, K.J., and R.B. Arlinghaus. 1991. Identification of T-cell epitopes without B-cell activity in the first and second conserved regions of the HIV env protein. AIDS 5:699-707.
39. Sastry, K.J., P.N. Nehete, S. Venkantnarayanan, J. Morkowski, C.D. Platsoucas, and R.B. Arlinghaus. 1992. Rapid in vivo induction of HIV-specific CD8+ cytotoxic T lymphocytes by a 15-amino acid unmodified free peptide from the immunodominant V3 loop of gp120. Virology 188:502-509.
40. Schendel, D.J., C. Reinhardt, P.J. Nelson, B. Maget, L. Pullen, G.W. Bornkamm, and A. Steinle. 1992. Cytotoxic T lymphocytes show HLA-C restricted recognition of EBV bearing cells and class I molecules presenting self peptides. J. Immunol. 149:2406-2416.
41. Sodoyer, R., M. Damotte, T.L. Delovitch, J. Trucy, B.R. Jordan, and T. Strachan. 1984. Complete nucleotide sequence of a gene encoding a functional human class I histocompatibility antigen (HLA-Cw3). EMBO J. 3:879-885.
42. van den Eynde, B., O. Peeters, O. de Backer, B. Gaugler, S. Lucas, and T. boon. 1995. A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma. J. Exp. Med. 182:689-698.
43. Walker, B.D., S. Chakrabarti, B. Moss, T.J. Paradis, T. Flynn, A.G. Durno, R.S. Blumberg, K.C. Kaplan, M.S. Hirsch, and R.T. Schooley. 1987. HIV-specific cytotoxic T lymphocytes in seropositive individuals. Nature 328:345-348.
44. Zemmour, J., and P. Parham. 1993. HLA class I nucleotide sequences. Immunogenetics 37:239-250.